144 related articles for article (PubMed ID: 18798089)
1. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles.
Zhou XJ; Hu XM; Yi YM; Wan J
Drug Dev Ind Pharm; 2009 Mar; 35(3):305-10. PubMed ID: 18798089
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
3. Ursolic acid nanoparticles for oral delivery prepared by emulsion solvent evaporation method: characterization, in vitro evaluation of radical scavenging activity and bioavailability.
Qiu L; Zhao X; Zu Y; Zhang Y; Liu Y; Wu W; Li Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):610-621. PubMed ID: 30831030
[TBL] [Abstract][Full Text] [Related]
4. Stealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in rats.
Zhang WL; Liu JP; Liu XX; Chen ZQ
Yao Xue Xue Bao; 2009 Dec; 44(12):1421-8. PubMed ID: 21348419
[TBL] [Abstract][Full Text] [Related]
5. Preparation of ursolic acid-phospholipid complex by solvent-assisted grinding method to improve dissolution and oral bioavailability.
Wang W; Zhang W; Jiang Y; Wang X; Zhang X; Liu H; Zhang T
Pharm Dev Technol; 2020 Jan; 25(1):68-75. PubMed ID: 31544585
[TBL] [Abstract][Full Text] [Related]
6. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
7. Sustained-release hydroxycamptothecin polybutylcyanoacrylate nanoparticles as a liver targeting drug delivery system.
Sun X; Wu F; Lu W; Zhang ZR
Pharmazie; 2004 Oct; 59(10):791-4. PubMed ID: 15544059
[TBL] [Abstract][Full Text] [Related]
8. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery.
Wang Z; Li Z; Zhang D; Miao L; Huang G
Drug Deliv; 2015 Jan; 22(1):79-85. PubMed ID: 24401038
[TBL] [Abstract][Full Text] [Related]
9. Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice.
Zheng J; Tang Y; Sun M; Zhao Y; Li Q; Zhou J; Wang Y
Pharmazie; 2013 Jan; 68(1):41-6. PubMed ID: 23444779
[TBL] [Abstract][Full Text] [Related]
10. Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review.
Jinhua W
Arch Pharm (Weinheim); 2019 Mar; 352(3):e1800222. PubMed ID: 30663087
[TBL] [Abstract][Full Text] [Related]
11. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
12. Enhanced bioavailability and hepatoprotectivity of optimized ursolic acid-phospholipid complex.
Biswas S; Mukherjee PK; Harwansh RK; Bannerjee S; Bhattacharjee P
Drug Dev Ind Pharm; 2019 Jun; 45(6):946-958. PubMed ID: 30767678
[TBL] [Abstract][Full Text] [Related]
13. Body distribution of camptothecin solid lipid nanoparticles after oral administration.
Yang S; Zhu J; Lu Y; Liang B; Yang C
Pharm Res; 1999 May; 16(5):751-7. PubMed ID: 10350020
[TBL] [Abstract][Full Text] [Related]
14. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
15. Major triterpenoids in Chinese hawthorn "Crataegus pinnatifida" and their effects on cell proliferation and apoptosis induction in MDA-MB-231 cancer cells.
Wen L; Guo R; You L; Abbasi AM; Li T; Fu X; Liu RH
Food Chem Toxicol; 2017 Feb; 100():149-160. PubMed ID: 28025124
[TBL] [Abstract][Full Text] [Related]
16. [Effect of diameter of adriamycin polybutylcyanoacrylate nanoparticles on liver targeting].
Shen LF; Wang X; Wang C; Zhao K; Liu XJ; Shen HJ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Oct; 31(5):732-6, 741. PubMed ID: 17062941
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
[TBL] [Abstract][Full Text] [Related]
18. Application of spray granulation for conversion of mixed phospholipid-bile salt micelles to dry powder form: influence of drug hydrophobicity on nanoparticle reagglomeration.
Lv Q; Li X; Shen B; Xu H; Shen C; Dai L; Bai J; Yuan H; Han J
Int J Nanomedicine; 2014; 9():505-15. PubMed ID: 24531119
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Mogroside V as a Promising Carrier in Drug Delivery: Improving the Bioavailability and Liver Distribution of Silybin.
Luo Y; Gong C; Wei M; Chen Y; Song T; Wu C; Mo L; Zhang J
AAPS PharmSciTech; 2020 Apr; 21(4):123. PubMed ID: 32337654
[TBL] [Abstract][Full Text] [Related]
20. [The study of cucurbitacin BE polylactic acid nanoparticles delivering cucurbitacin BE to metastasized cervical lymph nodes in mice with oral cancer].
Yang K; Wen Y; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):477-80. PubMed ID: 14732987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
